Oral anticoagulation is the therapeutic cornerstone in preventing thromboembolic risk in both atrial fibrillation (AF) and venous thromboembolism (VTE). After decades of the sole therapeutic oral anticoagulation option being warfarin, the introduction of non-vitamin K antagonist oral anticoagulants has heralded a new era. Edoxaban is the latest addition to these available for clinical use. Edoxaban was as effective and safer than warfarin in preventing thromboembolic risk in AF patients. Similarly, edoxaban effectiveness and safety was evident when treating VTE patients to prevent recurrent VTE or VTE-related death. Therefore, edoxaban represents a valuable alternative in treating thromboembolic risk for AF and VTE patients.
Edoxaban in venous thromboembolism and stroke prevention : an appraisal / M. Proietti, G.Y. Lip. - In: VASCULAR HEALTH AND RISK MANAGEMENT. - ISSN 1178-2048. - 12(2016 Feb 29), pp. 45-51. [10.2147/VHRM.S81569]
Edoxaban in venous thromboembolism and stroke prevention : an appraisal
M. ProiettiPrimo
;
2016
Abstract
Oral anticoagulation is the therapeutic cornerstone in preventing thromboembolic risk in both atrial fibrillation (AF) and venous thromboembolism (VTE). After decades of the sole therapeutic oral anticoagulation option being warfarin, the introduction of non-vitamin K antagonist oral anticoagulants has heralded a new era. Edoxaban is the latest addition to these available for clinical use. Edoxaban was as effective and safer than warfarin in preventing thromboembolic risk in AF patients. Similarly, edoxaban effectiveness and safety was evident when treating VTE patients to prevent recurrent VTE or VTE-related death. Therefore, edoxaban represents a valuable alternative in treating thromboembolic risk for AF and VTE patients.File | Dimensione | Formato | |
---|---|---|---|
Proietti_Edoxaban_2016.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
230.19 kB
Formato
Adobe PDF
|
230.19 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.